2024 |
Kalaris Therapeutics Inc.
|
Director |
- |
- |
2024 |
Alumis Inc.
|
Independent Director |
- |
- |
2024 |
Scholar Rock Holding Corp
|
Independent Director |
- |
- |
2024 |
Mineralys Therapeutics Inc
|
Independent Director |
- |
- |
2024 |
Syros Pharmaceuticals Inc.
|
Independent Director |
- |
- |
2023 |
Mineralys Therapeutics Inc
|
- |
607.3 K |
- |
2023 |
Scholar Rock Holding Corp
|
Independent Director |
291.2 K |
-26.1 % |
2023 |
Syros Pharmaceuticals Inc.
|
Independent Director |
78.2 K |
-56.6 % |
2022 |
Scholar Rock Holding Corp
|
Independent Director |
394.0 K |
- |
2022 |
Syros Pharmaceuticals Inc.
|
Independent Director |
180.3 K |
47.4 % |
2022 |
Mineralys Therapeutics Inc
|
Independent Director |
- |
- |
2021 |
Syros Pharmaceuticals Inc.
|
Independent Director |
122.3 K |
-19.9 % |
2020 |
Syros Pharmaceuticals Inc.
|
Independent Director |
152.7 K |
73.8 % |
2019 |
Syros Pharmaceuticals Inc.
|
Independent Director |
87.8 K |
-44.5 % |
2018 |
Syros Pharmaceuticals Inc.
|
Independent Director |
158.2 K |
-39.2 % |
2018 |
Atyr Pharma Inc
|
- |
19.6 K |
-81.8 % |
2018 |
Atyr Pharma Inc
|
Independent Director |
- |
- |
2017 |
Syros Pharmaceuticals Inc.
|
Director |
260.4 K |
- |
2017 |
Atyr Pharma Inc
|
Independent Director |
107.8 K |
-33.8 % |
2016 |
Atyr Pharma Inc
|
Independent Director |
162.9 K |
-6.2 % |
2015 |
Atyr Pharma Inc
|
Independent Director |
173.7 K |
- |
2014 |
Atyr Pharma Inc
|
Independent Director |
- |
- |
2009 |
Amarin Corp - ADR
|
Non-Executive Director |
- |
- |
2008 |
Amarin Corp - ADR
|
Non-Executive Director |
- |
- |